|
Prior authorization for FDA-approved PARP inhibitors in ovarian cancer
|
February 23, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology Reports
|
|
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumor-only versus paired tumor-normal sequencing
|
February 22, 2024
|
PC3I Authors Haley Newman |
Haematologica
|
|
The impact of an oncology urgent care center on healthcare utilization
|
February 20, 2024
|
PC3I Authors Christopher A. D’Avella |
JNCI Cancer Spectrum
|
|
Sex differences and racial/ethnic disparities in the presentation and treatment of medullary thyroid cancer
|
February 16, 2024
|
PC3I Authors Sara Ginzberg |
American Journal of Surgery
|
|
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
|
February 16, 2024
|
PC3I Authors Melina Marmarelis |
JTO Clinical and Research Reports
|
|
Belonging in Surgery: A validated instrument and single institutional pilot
|
February 13, 2024
|
PC3I Authors Sara Ginzberg |
Annals of Surgery
|
|
Comorbid Dementia and Cancer Therapy Decision-Making: A Scoping Review
|
February 13, 2024
|
PC3I Authors Tamara J. Cadet |
Journal of Applied Gerontology
|
|
Financial toxicity in gynecologic oncology: a multi-practice survey
|
February 12, 2024
|
PC3I Authors Anna Jo Smith; Meredith Doherty; Emily Ko |
International Journal of Gynecological Cancer
|
|
Cancer burden in low-income and middle-income countries
|
February 9, 2024
|
PC3I Authors Surbhi Grover |
Nature Reviews. Cancer
|
|
Artificial Intelligence and Technology Collaboratories: Innovating aging research and Alzheimer’s care
|
February 7, 2024
|
PC3I Authors George Demiris |
Alzheimer's & Dementia
|
|
Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?
|
February 6, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology
|
|
Federal Transportation Regulations Limit Access to Clinical Trials and Oncology Care
|
February 1, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
JAMA Oncology
|
|
Ethical dilemmas in prioritizing patients for scarce radiotherapy resources
|
January 31, 2024
|
PC3I Authors Larry Shulman |
BMC Medical Ethics
|
|
Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study
|
January 31, 2024
|
PC3I Authors Larry Shulman |
BMJ Open
|
|
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era
|
January 31, 2024
|
PC3I Authors Michelle Iocolano; Charu Aggarwal |
Cancer
|
|
Urologist-level variation in the management of T1a renal cell carcinoma: A population-based cohort study
|
January 26, 2024
|
PC3I Authors Daniel Lee |
Urologic Oncology
|
|
In utero hematopoietic cell transplantation leads to sustained engraftment in a mouse model of Fanconi anemia
|
January 26, 2024
|
PC3I Authors Cara Berkowitz |
Blood Advances
|
|
Family Caregiver Communication and Perceptions of Involvement in Hospice Care
|
January 25, 2024
|
PC3I Authors George Demiris |
Journal of Palliative Medicine
|
|
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy
|
January 25, 2024
|
PC3I Authors Emily Ko |
Current Treatment Options in Oncology
|
|
An NLP Framework for the Extraction of Concept Measurements from Radiology and Pathology Notes
|
January 25, 2024
|
PC3I Authors Anil Vachani; Jennifer Steltz |
Studies in Health Technology and Informatics
|
